<DOC>
	<DOCNO>NCT00415987</DOCNO>
	<brief_summary>The treatment assignment base presence absence HLA-identical sibling donor ( Genetic Randomisation , NOT formal Randomisation ) . Patients suitable HLA-identical sibling donor offer tandem transplant approach consist standard autografting nonmyeloablative radiotherapy allografting . Patients without HLA-identical sibling treat standard double autologous transplantation per Institutional guideline enrol treatment program approve local IRBs.This multi-center study . The Division Hematology University Torino S.G.B . Hospital , Torino , Italy , co-ordinating Center .</brief_summary>
	<brief_title>Hematopoietic Stem Cell Transplantation Myeloma</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>DurieSalmon stage IIAIIIB multiple myeloma ; Age &gt; 18 â‰¤ 65 year ; previously untreated myeloma ; presence sibling ( potential donor ) ; bilirubins &lt; twice normal ; ALAT ASAT &lt; four time normal ; leave ventricular ejection fraction &gt; 40 % ; creatinine clearance &gt; 40 mL/min ; Pulmonary dysfunction diffuse capacity carbon monoxide ( DLCO ) &gt; 40 % and/or need continuous oxygen supplementation ; Karnofsky performance status &gt; 60 % ; patient must give write informed consent ; Age &gt; 65 year previously treat myeloma ; absence sibling ( genetic randomisation apply ) ; Karnofsky performance status score &lt; 60 % HIVinfection ; pregnancy ; Refusal use contraceptive technique 12 month follow treatment patient unable give write informed consent PS . Informed consent obtain patient accord Institutional Review Boards participate center . The study conduct accord Declaration Helsinki .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Multiple Myeloma</keyword>
</DOC>